Skip to content

Advertisement

  • Meeting abstract
  • Open Access

Hemodynamics in induced whole body hyperthermia

  • 1,
  • 1,
  • 1,
  • 2,
  • 2,
  • 3,
  • 1 and
  • 1
Critical Care19982 (Suppl 1) :P001

https://doi.org/10.1186/cc131

  • Published:

Keywords

  • Cardiac Index
  • Pulmonary Vascular Resistance
  • Systemic Vascular Resistance
  • Pulmonary Arterial Pressure
  • Volatile Anaesthetic

Background

Whole body hyperthermia induced by radiative systems has been used in therapy of malignant diseases for more than ten years. Von Ardenne and co-workers have developed the 'systemiche Krebs-Mehrschritt-Therapic' (sKMT), a combined regime including whole body hyperthermia of 42°C, induced hyperglycaemia and relative hyperoxaemia with additional application of chemotherapy. This concept has been employed in a phase I/II clinical study for patients with metastatic colorectal carcinoma at the Virchow-Klinikum since January 1997.

Methods

The sKMT concept was performed eleven times under intravenous general anaesthesia, avoiding volatile anaesthetics. Core temperatures of up to 42°C were reached stepwise by warming with infrared-A-radiation (IRATHERM 2000®). During the whole procedure blood glucose levels of 380–450 mg/dl were maintained as well as PaO2 levels above 200 mmHg. Extensive invasive monitoring was performed in all patients including measurements with the REF-Ox-Pulmonary artery catheter with continuous measuring of mixed venous saturation (Baxter Explorer®) and invasive monitoring of arterial blood pressure. Data for calculation of hemodynamic and gas exchange parameters were collected four times, at temperatures of 37°C, 40°C, 41.8–42°C and 39°C, during measurements FiO2 was 1.0 at all times. Fluids were given in order to keep central-venous and Wedge pressure within normal range during the whole procedure. Statistics were performed using the Wilcoxon Test.

Results

Statistically significant differences were found between heart rate, cardiac index and systemic vascular resistance comparing data at 37°C and 42°C. Heart rate and cardiac index increased to a maximum at 42°C (P < 0.0001) whereas systemic vascular resistance had its minimum at 42°C (P < 0.0001). Mean arterial pressure dropped with increasing temperature, differences were not significant. Calculation of stroke volume index and ventricular volumes showed only a slight decrease in endsystolic volumes with increasing temperature, the resulting differences in right ventricular ejection fraction were marginally significant (P = 0.038) comparing 42°C to baseline. Right ventricular stroke work index as well as mean pulmonary arterial pressure increased at 42°C (P = 0.0115 and P = 0.0037), pulmonary vascular resistance only dropped little compared to systemic vascular resistance, left ventricular stroke work index even dropped with increasing temperature, though showing no significant difference. Values for mixed venous oxygen saturation did not vary during therapy, pulmonary right-left shunt showed a temperature associated increase (P = 0.0323) to a maximum at 42°C.

Conclusion

Under the procedure of sKMT cardiac function in patients, who do not have any pre-existing cardiac impairment, can be maintained almost unchanged, ie with normal right and left ventricular pressure, despite an increase in right ventricular stroke work

Declarations

Acknowledegment

Supported by Deutsche Krebshilfe.

Authors’ Affiliations

(1)
Abteilung für Anaesthesiologic und operative Intensivmedizin, Virchow-Charité der Humboldt-Universität zu Berlin, Deutschland
(2)
Abteilung für Hämatologiel Onkologie, Virchow-Charité der Humboldt-Universität zu Berlin, Deutschland
(3)
Abteilung für Strahlenklinik und poliklinik, Virchow-Charité der Humboldt-Universität zu Berlin, Deutschland

Copyright

© Current Science Ltd 1998

Advertisement